Dow Down0.03% Nasdaq Up0.17%

Ampio Pharmaceuticals, Inc. (AMPE)

-NYSE MKT
3.72 Up 0.16(4.49%) 9:42AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 50   50   19  
Cost of Revenue -   -   -  
Gross Profit 50   50   19  
Operating Expenses
Research Development18,289  7,494  6,648  
Selling General and Administrative5,785  4,377  4,504  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (24,024) (11,821) (11,134)
Income from Continuing Operations
Total Other Income/Expenses Net(505)228  (7,134)
Earnings Before Interest And Taxes(24,528)(11,593)(18,268)
Interest Expense -   -  8  
Income Before Tax(24,528)(11,593)(18,277)
Income Tax Expense -   -  83  
Minority Interest520   -   -  
Net Income From Continuing Ops(24,009)(11,593)(18,359)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (24,009) (11,593) (18,359)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (24,009) (11,593) (18,359)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.